Home/Filings/4/0001209191-23-033735
4//SEC Filing

WIRTH PETER 4

Accession 0001209191-23-033735

CIK 0001556263other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:26 PM ET

Size

7.3 KB

Accession

0001209191-23-033735

Insider Transaction Report

Form 4
Period: 2023-06-01
WIRTH PETER
Director
Transactions
  • Award

    Common Stock

    2023-06-01+4,00012,000 total
  • Award

    Stock Option (right to buy)

    2023-06-01+6,0006,000 total
    Exercise: $3.70Exp: 2033-05-31Common Stock (6,000 underlying)
Footnotes (1)
  • [F1]The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments of 8.33% of the shares underlying the award until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date.

Issuer

Syros Pharmaceuticals, Inc.

CIK 0001556263

Entity typeother
IncorporatedMA

Related Parties

1
  • filerCIK 0001021041

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:26 PM ET
Size
7.3 KB